Ruxolitinib cream reached Lecheng in August 2023 under the zone’s early-access policy and quickly became one of its most sought-after products. A year on, more than 5,000 patients had been treated. The article follows three of them — including a man from Chongqing who had lived with vitiligo since middle school, twenty years in all — through clinics that fill up whenever Prof. Zhang Xuejun of Boao Super Hospital’s dermatology centre is in town.
2023 年 8 月，白癜风创新药芦可替尼乳膏依托先行先试政策落地乐城，很快成为“爆款”。落地一年多，已有超过 5000 名患者因此受益。文章跟访了其中三位——包括一位初中起病、患病 20 年、专程从重庆飞来的患者——博鳌超级医院皮肤医学中心张学军教授每次坐诊，候诊队伍都排成长龙。
This page is a short English/Chinese summary of the facts in a patient story published by the Lecheng Administration. Photos are from that publication, credited; a link to the original Chinese article sits at the foot of this page. 本页是对Lecheng Administration发布的一篇患者故事中事实的简短中英摘要。照片取自该发布并标注来源；官方中文原文链接见本页页脚。
